Clinical Trial Update: Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating atorvastatin to prevent occlusion and restenosis after intracranial artery stenting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Intracranial Artery Stenosis
• Intracranial Atherosclerotic Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Jinling Hospital, China | Conditions: CVD | Phase 4 | Status: COMPLETED